Wellness Resources, Inc. FDA Warning (2017)
Compiled by the Supplement Safety Data Team | Sourced from Official FDA Records on November 30, 2017
Executive Summary
The FDA issued a warning letter to Wellness Resources, Inc. on November 30, 2017 citing regulatory violations. Consumers who have purchased products from this company should exercise caution. The letter was issued by Minneapolis District Office.
Detailed Analysis
False Claims and Regulatory Violations
“New research has shown for the first time that omega-3 in fish oil (DHA/EPA) [an ingredient in your DHA Daily, DHA Kids, and Lepnital] could substantially and significantly reduce the signs and symptoms of osteoarthritis. There was strong evidence that omega-3 influences the biochemistry of the disease, and therefore not only helps prevent disease, but also slows its progression, potentially controlling established osteoarthritis….”
Potential Health Risks
Consumers should be aware of potential risks associated with products from Wellness Resources, Inc..
Regulatory Context
“[T]he biologically active extract of green tea…slows down cancer in patients with chronic lymphocytic leukemia.”
Key Entities Identified
Frequently Asked Questions
- What did the FDA find wrong with Wellness Resources, Inc.?
- The FDA issued a warning letter citing regulatory violations related to their products or manufacturing practices.
- Are Wellness Resources, Inc. products safe to use?
- Based on the FDA's findings, consumers should exercise caution. The company was found to have regulatory issues that may affect product safety.
- What should I do if I've used Wellness Resources, Inc. products?
- If you have used products from Wellness Resources, Inc. and experience any adverse effects, contact your healthcare provider immediately. You can also report adverse events to the FDA's MedWatch program.
Source Document
This report is based on an official FDA warning letter. The original document is a public record.
View Original FDA Warning Letter